Olfactory Ensheathing Cells (OECs) are a unique type of glial cell predominantly located in the olfactory system, specifically the olfactory bulb and olfactory nerve. Central to the sense of smell, OECs play a vital role in supporting and guiding olfactory nerve fibers, contributing to the continuous turnover of olfactory receptor neurons. What distinguishes OECs is their remarkable regenerative capacity, making them a focus of extensive research for potential therapeutic applications in nerve injuries and neurodegenerative diseases. These cells create a conducive environment for axonal growth and regeneration, aiding in the repair of damaged nerve fibers. Beyond their role in the olfactory system, OECs have shown promise in spinal cord injury treatments, acting as a glial bridge to guide regenerating axons. Researchers explore OEC transplantation for its potential in promoting nerve regeneration, finding applications in various contexts, including multiple sclerosis and retinal nerve injuries. OECs express neurotrophic factors and exhibit immunomodulatory effects, further contributing to their therapeutic potential. Harvesting OECs from the olfactory mucosa for transplantation purposes has been investigated, showcasing their migratory capabilities and reparative effects. As the field advances, ongoing studies delve into the molecular mechanisms underlying OEC-mediated regeneration, aiming to harness their regenerative prowess for broader applications in both the peripheral and central nervous systems.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Will be updated soon...
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : Will be updated soon...
Nagy Habib, Imperial College London, United Kingdom
Title : Will be updated soon...
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : Developing iPSC-derived 3D Outer Blood-Retinal Barrier Disease Models of Choroideremia for Gene Therapy Evaluation
Aradhana Kasimsetty, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States